Table 2.
Term | Description | Count | P-value |
---|---|---|---|
Model 1 | |||
hsa04110 | Cell cycle | 5 | 3.38E-06 |
Model 2 | |||
hsa05200 | Pathways in cancer | 7 | 1.21E-05 |
hsa04916 | Melanogenesis | 5 | 1.28E-05 |
hsa04310 | Wnt signaling pathway | 5 | 4.59E-05 |
hsa05217 | Basal cell carcinoma | 4 | 7.22E-05 |
hsa04550 | Pathways regulating pluripotency of stem cells | 4 | 0.001208 |
hsa04390 | Hippo signaling pathway | 4 | 0.001503 |
hsa05205 | Proteoglycans in cancer | 4 | 0.003362 |
hsa05166 | HTLV-I infection | 4 | 0.006586 |
hsa04062 | Chemokine signaling pathway | 3 | 0.034067 |
Model 3 | |||
hsa00830 | Retinol metabolism | 4 | 4.16E-05 |
hsa00350 | Tyrosine metabolism | 3 | 0.000691 |
hsa00982 | Drug metabolism - cytochrome P450 | 3 | 0.002595 |
hsa04530 | Tight junction | 3 | 0.004214 |
hsa04670 | Leukocyte transendothelial migration | 3 | 0.007264 |
hsa05160 | Hepatitis C | 3 | 0.009625 |
hsa04514 | Cell adhesion molecules (CAMs) | 3 | 0.01092 |
hsa00071 | Fatty acid degradation | 2 | 0.047837 |
Abbreviations: KEGG, Kyoto Encyclopedia of Genes and Genomes; Wnt, wingless integrated; PPI, protein–protein interaction.